# A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C

> **NCT00890318** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 32 (actual)

## Conditions studied

- HCV Infection

## Interventions

- **DRUG:** ABT-072
- **OTHER:** ketoconazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00890318
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-07
- **Final completion:** —
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2010-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890318, "A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00890318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*